Approval announcement from the UK Medicines and Healthcare products Regulatory Agency (MHRA)

Oxford/AstraZeneca Scientists Develop Bubonic Plague Vaccine for Black Death Amid UK Stockpile Concerns

Jan 4, 2025, 06:35 PM

Scientists from Oxford University and AstraZeneca are developing a vaccine for the bubonic plague, responding to concerns about a potential superbug strain of the Black Death. Military experts have advised the UK government to stockpile supplies of this new inoculation. The initiative follows the team's previous work on the Covid-19 vaccine, highlighting ongoing efforts to prepare for emerging infectious diseases.